The effects of vildagliptin in addition to insulin on glycaemic control in haemodialysis patients with type 2 diabetes mellitus
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 24 Nov 2014
At a glance
- Drugs Vildagliptin (Primary) ; Insulin
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- 13 Dec 2013 Planned End Date (13 May 2014) added as reported by University Hospital Medical Information Network - Japan.
- 13 Dec 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 14 May 2013 New trial record